Ad Promo Review in Pharma - How Far is Too Far? episode artwork

EPISODE · Nov 16, 2024 · 14 MIN

Ad Promo Review in Pharma - How Far is Too Far?

from DarshanTalks Podcast · host Darshan Kulkarni

Send us Fan MailKatie Graham and I discuss various aspects of FDA and FTC regulations, including ad promo, the Chevron decision, and the evolving role of compliance in the pharmaceutical industry.Key topics include:What is Ad Promo?Chevron decision's influence on FDA/FTCShould administrative agencies cite letters? Can the FDA establish rules after someone challenges them?Uncertainty of Compliance White SpaceIs regulatory medical advice now just seen as a risk?Support the showwww.kulkarnilawfirm.com

Episode metadata supplied by the publisher feed · Published Nov 16, 2024

Embed this episode

NOW PLAYING

Ad Promo Review in Pharma - How Far is Too Far?

0:00 14:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of DarshanTalks Podcast?

This episode is 14 minutes long.

When was this DarshanTalks Podcast episode published?

This episode was published on November 16, 2024.

Can I download this DarshanTalks Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!